Results 41 to 50 of about 7,348 (201)

Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database

open access: yesBMC Gastroenterology, 2013
Background Although high non-adherence to medication has been noticed for ulcerative colitis (UC), little is known about adherence to mesalamine treatments and determinants that can predict adherence.
Lachaine Jean   +3 more
doaj   +1 more source

Patients' Experiences at the Inflammatory Bowel Disease Outpatient Clinic During the Pandemic—Healthcare Service Offer and Apprehension of Consequences of COVID‐19

open access: yesJCC Plus, Volume 1, Issue 1, January 2026.
ABSTRACT Aim The COVID‐19 pandemic caused substantial changes in the routine management of patients with inflammatory bowel disease (IBD). The aim of this study was to survey the experience and the concerns of patients at the IBD outpatient clinic two years after the beginning of the pandemic.
Benoit Follin‐Arbelet   +2 more
wiley   +1 more source

Drugs in focus: Budesonide and its role in paediatric gastrointestinal disorders

open access: yesJournal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 1, Page 60-69, January 2026.
Abstract Budesonide is a glucocorticoid with strong topical anti‐inflammatory properties and minimal systemic effects due to extensive first‐pass hepatic metabolism. It is designed for targeted delivery within the gastrointestinal (GI) tract and is available in oral and rectal formulations.
Sohail Aziz   +11 more
wiley   +1 more source

Chemoprevention with a tea from hawthorn (Crataegus oxyacantha) leaves and flowers attenuates colitis in rats by reducing inflammation and oxidative stress

open access: yesFood Chemistry: X, 2021
The purpose of the study was to determine the effects of a tea from the leaves and flowers of Crataegus oxyacantha in rats with colitis. Colitis was induced by administration of 2,4,6-trinitrobenzene sulfonic acid. Hawthorn tea (HT) (100 mg/kg) was given
Roberto de Paula do Nascimento   +12 more
doaj   +1 more source

The Impact of Disease Activity and Medications on Pregnancy and Fetal Outcomes in Women With Inflammatory Bowel Disease: A Cohort Study From the IBD‐ME Group

open access: yesJournal of Gastroenterology and Hepatology, Volume 41, Issue 1, Page 155-167, January 2026.
ABSTRACT Background Women with inflammatory bowel disease (IBD) and their children are at higher risk of adverse outcomes. The primary aim was to examine the association between IBD and adverse pregnancy outcomes. The secondary aim was to assess the impact of maternal IBD and medications used on children's outcomes.
Nahla Azzam   +14 more
wiley   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists Are Associated With Improved Outcomes in Inflammatory Bowel Disease

open access: yesGastroHep, Volume 2026, Issue 1, 2026.
Background The co‐existence of diabetes and obesity in patients with inflammatory bowel disease (IBD) increases morbidity and mortality associated with IBD, yet it remains unclear how medications used to treat these metabolic disorders affect IBD course.
Michael Saadeh   +8 more
wiley   +1 more source

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine

open access: yesClinical Pharmacology: Advances and Applications, 2012
Kavinderjit Nanda, Alan C MossCenter for Inflammatory Bowel Disease, BIDMC/Harvard Medical School, Boston, MA, USAAbstract: Ulcerative colitis (UC) is a chronic inflammatory disease of the colon that typically manifests as diarrhea, abdominal pain, and ...
Nanda K, Moss AC
doaj  

Fibers and Polyphenols in Diverticular Disease: From Pathophysiology to Management

open access: yesNeurogastroenterology &Motility, Volume 37, Issue 12, December 2025.
ABSTRACT Backgrounds Diverticular disease, particularly symptomatic uncomplicated diverticular disease (SUDD), significantly impacts patient quality of life and is increasing in prevalence, especially in Western countries. While its pathophysiology is multifactorial, diet—specifically low fiber intake—has been implicated as a key modifiable factor in ...
Claudia Marinaccio   +8 more
wiley   +1 more source

Tumor Necrosis Factor Inhibitors and Risk of Serious Infections in Pregnant Women With Chronic Inflammatory Diseases

open access: yesACR Open Rheumatology, Volume 7, Issue 11, November 2025.
Objective Tumor necrosis factor inhibitors (TNFi) are used by over 20% of pregnant women with chronic inflammatory diseases, which could further impede immune function and increase the risk of infections that require hospitalization. We assessed the risk of serious infections during pregnancy and postpartum between women exposed and unexposed to TNFi ...
Leah K. Flatman   +6 more
wiley   +1 more source

Multiple Sampling Capsule Robot for Studying Gut Microbiome

open access: yesAdvanced Intelligent Systems, Volume 7, Issue 11, November 2025.
A multiple sampling capsule robot (MSCR) is developed for longitudinal gut microbiome analysis. Employing electromagnetic field control, the MSCR can locomote actively, precisely align the selected channel, and collect up to six microbiome samples with minimal cross‐contamination.
Sanghyeon Park   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy